首页>
外国专利>
USE OF INTRAPUTAMINAL INFUSED GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR IN THE TREATMENT OF PARKINSONaCOES DISEASE IN HUMANS.
USE OF INTRAPUTAMINAL INFUSED GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR IN THE TREATMENT OF PARKINSONaCOES DISEASE IN HUMANS.
展开▼
机译:腹腔注射胶质细胞源性神经营养因子在治疗帕金森氏病中的应用。
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method of treating Parkinson's disease in humans is disclosed, wherein glial cell-line derive neurotrophic factor (GDNF) is chronically administered directly to one or both putamen of a human in need of treatment thereof. In one aspect of the present invention the GDNF is infused directly into one or both putamen through one or more indwelling intraparenchymal brain catheters connected to an implantable pump.
展开▼